Weizhong Tang

2.2k citations
105 papers · 1.5k indexed · h-index 22
Topics
RNA modifications and cancer (11 papers)Colorectal Cancer Surgical Treatments (10 papers)Cancer-related molecular mechanisms research (10 papers)
Journals
The Journal of Chemical PhysicsSHILAP Revista de lepidopterologíaPLoS ONE
Partner nations
ChinaUnited States

In The Last Decade

Weizhong Tang

101 papers receiving 1.5k citations

Peers

Weizhong Tang
Comparison fields: 5 of 125
  • Molecular Biology 634
  • Oncology 381
  • Cancer Research 297
  • Biomedical Engineering 233
  • Pulmonary and Respiratory Medicine 230
Replace Zhengxiang Zhang with:
Zhengxiang Zhang China
You Qin China
Qiu Li China
Xiaofei Wen China
Zhaoyang Zhong China
Alessandro Corti Italy
Jianmin Wang China
Bo Ye China
Weizhong Tang relative to Zhengxiang Zhang China Zhengxiang Zhang's profile →
Citations per field
00.5×1.7×
Zhengxiang Zhang · 1×
Citations per year

Countries citing papers authored by Weizhong Tang

Since Specialization
Citations

This map shows the geographic impact of Weizhong Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weizhong Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weizhong Tang more than expected).

Fields of papers citing papers by Weizhong Tang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weizhong Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weizhong Tang. The network helps show where Weizhong Tang may publish in the future.

Co-authorship network of co-authors of Weizhong Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Weizhong Tang. A scholar is included among the top collaborators of Weizhong Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weizhong Tang. Weizhong Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 9
4 5
5 0
6 11
7 1
8 1
9 3
10 8
11 32
12 81
13 2
14 2
15 11
16 65
17 5
18 13
19 2
20 18

About Weizhong Tang

Weizhong Tang is a scholar working on Cancer Research, Oncology and Gastroenterology, having authored 105 papers that have together received 1.5k indexed citations. Recurring topics across this work include RNA modifications and cancer (11 papers), Colorectal Cancer Surgical Treatments (10 papers) and Cancer-related molecular mechanisms research (10 papers). The work is most often cited by research in Cancer Research (297 citations), Oncology (381 citations) and Electrochemistry (63 citations). Weizhong Tang has collaborated with scholars based in China and United States. Frequent co-authors include Xiaoliang Huang, Jungang Liu, Xue Qin, Xianwei Mo, Fei Yan, Qiliu Peng, Jiyang Liu, Jian Wang, Yanqiong Liu and Yan Deng. Their work appears in journals such as The Journal of Chemical Physics, SHILAP Revista de lepidopterología and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026